Go Ad-Free
    My Alerts
    Moneycontrol
    Moneycontrol PRO
    Loans
    Loans
    HomeNewsAurobindopharma

    Stock analysis is used by traders to make buy and sell call. It’s an approach to make informed decisions while investing in stocks. Stock analysis can be categorised into – fundamental analysis and technical analysis. Fundamental analysis is evaluation of data from sources, including financial records, economic reports, company assets, and market share. Analysts typically study the company’s financial statements – balance sheet, income statement, cash flow statement, and footnotes. These statements are made available to the investors in the form of quarterly earnings, disclosures to stock exchanges in compliance with the Securities and Exchange Board of India (Sebi) norms. In fundamental analysis, the analysts particularly check for a company's core income, income from other sources, profitability, guidance, assets and liabilities and debt ratio among other parameters. The other method, i.e. the technical analysis focuses purely on statistical data. It works on two assumptions; one, the stock price reflects the fundamentals. Second, the study of past and present movement in prices can help determine the future price trends. Technical analysis primarily deals with price, volume, demand and supply factors. This method is effective only when supply and demand forces influence the market. However, when outside factors are involved in a price movement, technical analysis may not be successful. More

    Jump to

    • Here are fundamental trading ideas from SP Tulsian

      In an interview to CNBC-TV18’s Latha Venkatesh, Anuj Singhal, and Sonia Shenoy, SP Tulsian of sptulsian.com shared his readings and outlook on market and specific stocks.

    • Buy, sell, hold: These 3 stocks are on analysts’ radar today

      Voltas, Navneet Education and Kotak Mahindra Bank are on the watch list of analysts. Meanwhile, insurance, pharma and autos are also in focus.

    • Prefer Cipla, Aurobindo Pharma: Gaurang Shah

      According to Gaurang Shah of Geojit Financial Services, one may prefer Cipla and Aurobindo Pharma.

    • Sell Strides Shasun, Aurobindo Pharma: Mitessh Thakkar

      Mitessh Thakkar of miteshthacker.com recommends selling Strides Shasun and Aurobindo Pharma.

    • Here are a few investment ideas by SP Tulsian

      In an interview to CNBC-TV18's Latha Venkatesh, Sonia Shenoy and Anuj Singhal, SP Tulsian of sptulsian.com shared his reading and outlook on the market and also gave recommendations on various stocks.

    • Buy Asian Paints on all dips; Aurobindo Pharma may test Rs 850: Ashwani Gujral

      According to Ashwani Gujral of ashwanigujral.com, one can buy Asian Paints on all dips while he feels that Aurobindo Pharma may test Rs 850.

    • Buy Reliance Industries at lower levels, prefer pharma: Ashwani Gujral

      Ashwani Gujral of ashwanigujral.com is of the view that one can buy Reliance Industries at lower levels and prefers pharma.

    • Aurobindo Pharma may test Rs 710, Nestle India can hit Rs 6350: Prakash Gaba

      Prakash Gaba of prakashgaba.com is of the view that Aurobindo Pharma may test Rs 710 while Nestle India can hit Rs 6350.

    • Buy Unichem Labs, Aurobindo Pharma , PC Jeweller: Ashwani Gujral

      Ashwani Gujral of ashwanigujral.com is of the view that one can buy Unichem Labs, Aurobindo Pharma and PC Jeweller.

    • Buy Aurobindo Pharma, Escorts; sell BEML: Ashwani Gujral

      According to Ashwani Gujral of ashwanigujral.com, one can buy Aurobindo Pharma and Escorts and sell BEML.

    • Fund managers are not gung-ho on these 20 stocks; do you have them in your portfolio?

      Rising liquidity in domestic MFs is one of the biggest factors in driving rally on D-Street which is trading at record highs.

    • Aurobindo Pharma may move to Rs 820, says Rajat Bose

      Rajat Bose of rajatkbose.com feels that Aurobindo Pharma may move to Rs 820.

    • Here are a few investment ideas from SP Tulsian

    • New launches in US, margin expansion to aid Aurobindo: Goldman

      Research firm is upbeat on the stock citing these reasons; sets target price of Rs 934 with an upside potential of 40 percent.

    • Buy, sell, hold: 6 stocks to watch out for your portfolio

      Aurobindo Pharma, the seventh largest generics manufacturer in the US by volume, is transforming from a simple generics player to one with a portfolio of more complex generics, Goldman Sachs says.

    • Buy Arvind, Tata Comm, Sun TV; sell Auro Pharma: Sukhani

      Sudarshan Sukhani of s2analytics.com suggests buying Arvind, Tata Comm, Sun TV and Mindtree and advises selling Aurobindo Pharma.

    • Buy Bajaj Auto, sell Aurobindo Pharma: Mitessh Thakkar

      Mitessh Thakkar of miteshthacker.com has a buy on Bajaj Auto with a target of Rs 2900 and has a sell on Aurobindo Pharma with a target of Rs 655.

    • Here are top trading ideas from Rahul Arora

      In an interview to CNBC-TV18's Prashant Nair and Sumaira Abidi, Rahul Arora, CEO at Nirmal Bang Institutional Equities shared his readings and outlook on market and specific stocks.

    • Buy, sell, hold: 19 stocks that analysts are watching out today

      Deutsche Bank's largecap picks are Aurobindo Pharma, BPCL, Maruti Suzuki, NTPC, SBI, Shree Cement, Tata Motors, TCS, Tech Mahindra and Vedanta India.

    • Top trading ideas by SP Tulsian

      In an interview to CNBC-TV18 SP Tulsian, sptulsian.com shared his reading and outlook on the market and also gave recommendations on various stocks.

    • Stay invested in Aurobindo Pharma: Prakash Gaba

      Prakash Gaba of prakashgaba.com is of the view that one may stay invested in Aurobindo Pharma.

    • Here‘s why Deutsche Bank is upbeat on pharmaceutical sector

      Easing regulatory concerns and actions by the US Food and Drug Administration (FDA) will help the sector and improve investor sentiment, Deutsche Bank said in a report.

    • Buy Aurobindo Pharma, Dish TV, Hero MotoCorp: Ashwani Gujral

      Ashwani Gujral of ashwanigujral.com recommends buying Aurobindo Pharma, Dish TV and Hero MotoCorp.

    • Here is why SP Tulsian is bullish on Petronet LNG

      SP Tulsian of sptulsian.com, explains why he is bullish on Petronet LNG. He also discusses key pharma sector likes Cadila Healthcare, Divis Laboratories and Aurobindo Pharma.

    • Dilip Bhat positive on pharma sector

      Dilip Bhat of Prabhudas Lilladher is positive on the pharma sector largely because of the growth factor and because of the profitabilities.

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347